Clinical Trial of Concomitant Hip Arthroscopy During PAO

Description

The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.

Conditions

Hip Dysplasia

Talk to us

Study Overview

On this page

Study Details

Study overview

The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.

Single-Blind Randomized Clinical Trial of Concomitant Hip Arthroscopy During Periacetabular Osteotomy for the Management of Hip Dysplasia

Clinical Trial of Concomitant Hip Arthroscopy During PAO

Condition
Hip Dysplasia
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of hip dysplasia (DDH) electing periacetabular osteotomy (PAO) for treatment
  • * Skeletally mature
  • * Age 15 - 55
  • * Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis)
  • * Ability to receive a standard of care preoperative (magnetic resonance imaging) MRI arthrogram of the hip
  • * Pregnant women
  • * Previous surgery about the hip
  • * Patients receiving PAO for acetabular retroversion in the absence of DDH
  • * Previous hip arthroscopy to address intra-articular pathology

Ages Eligible for Study

15 Years to 55 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Rafael Sierra, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2026-06